SCHEMBL18576791

SCHEMBL18576791

CCOC(=O)CCC(Cc1ccc(-c2ccccc2)cc1)N1C(=O)C=CC1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMEL1 Q495T6 2/20 0.43
▸ PTPN1 P18031 1/20 0.42
▸ GSK3A P49840 1/20 0.42
▸ GSK3B P49841 1/20 0.42
▸ SRR Q9GZT4 2/20 0.41
▸ PSAT1 Q9Y617 2/20 0.41
▸ ATM Q13315 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ HTT P42858 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ MME P08473 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ NOD2 Q9HC29 1/20 0.39
▸ FAAH O00519 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18576792 1.00 MMEL1 (0.43) MMEL1PTPN1GSK3AGSK3BSRR
SCHEMBL20072199 0.87 ALDH1A1 (0.43) MMEL1PTPN1SRRPSAT1ATM
SCHEMBL18554190 0.84 FFAR1 (0.51) MMEL1HTTMEN1KMT2AMME
SCHEMBL18576790 0.84 FFAR1 (0.51) MMEL1HTTMEN1KMT2AMME
SCHEMBL30300760 0.81 MME (0.41) MMEFAAHMGLL
SCHEMBL597533 0.78 SRR (0.50) MMEL1PTPN1SRRPSAT1ATM
SCHEMBL1908571 0.78 SRR (0.50) MMEL1PTPN1SRRPSAT1ATM
Hydrochloric Acid SCHEMBL597532 0.77 SRR (0.51) MMEL1PTPN1SRRPSAT1ATM
Hydrochloric Acid SCHEMBL597534 0.77 SRR (0.51) MMEL1PTPN1SRRPSAT1ATM
SCHEMBL18554256 0.75 PPARG (0.44) MEN1KMT2AMMECYP1A2FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017033128-A1 BIPHENYL-SUBSTITUED 4-AMINO-BUTYRIC ACID DERIVATIVES AND THEIR USE IN THE SYNTHESIS OF NEP INHIBITORS NOVARTIS AG (CH) 2017-03-02 — — WO disclosed
Send feedback